Physician profile
Timothy Ortiz
NPI 1710038690
$1,438.86
in general payments reported to CMS, 2019-2025
14 companies · $184 in 2025
The $184 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $427 · 2020: $107 · 2021: $317 · 2022: $171 · 2023: $140 · 2024: $92.70 · 2025: $184.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $417.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $417.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $530.27 | 2019-2025 | Dailies, Precision 1, Dailies Total1 |
| Sight Sciences, INC. | $194.79 | 2019-2022 | |
| Bausch & Lomb Americas INC. | $150.97 | 2022-2025 | Infuse, Biotrue |
| Abbvie INC. | $145.44 | 2023-2025 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $124.99 | 2021 | |
| Coopervision INC. | $119.62 | 2019-2025 | Clariti Contact Lens, Myday Contact Lens |
| Carl Zeiss Meditec Ag | $38.80 | 2020 | |
| Optos, INC. | $25.29 | 2022 | |
| Novartis Pharmaceuticals Corporation | $22.64 | 2020 | |
| Aerie Pharmaceuticals, INC. | $22.56 | 2019 | |
| Visioneering Technologies, INC. | $21.25 | 2023 | |
| Oyster Point Pharma, INC. | $14.98 | 2022 | |
| Allergan, INC. | $13.75 | 2021 | |
| Tearlab Corp | $13.51 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Ortiz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.